Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Eileen H. Shinn Image

      Eileen H. Shinn, PhD

      Department of Behavioral Science, Division of Cancer Prevention and Population Sciences

      About Dr. Shinn

      Eileen H. Shinn, PhD, is an Associate Professor in the Department of Behavioral Science. She holds a Ph.D. in clinical psychology from Ohio University. Her research interests include behavioral interventions for patients on active treatment, increasing engagement to supportive mobile technology, and long-term adherence to chronic regimens in cancer. As part of this research, she collaborates with experts in radiation oncology, nanoengineering, computational science and pathology. Her long-term goal is to link psychosocial applications with emerging and established clinical strategies to improve QoL in both early-stage and advanced cancer.

      Her interest in adherence research has focused mainly in head and neck cancer: her most recent project translated a 10-session adherence intervention for patients with head and neck cancer to a mobile platform for rural patients in North Central Texas (CPRIT Prevention Program grant). She was PI of several grants testing the efficacy and feasibility of adherence interventions in patients with head and neck cancer (R01DE019141; ACS RSGPB-09-156-01-CPPB; the PREPARE adherence intervention was recognized at the 2016 Dysphagia Conference by the American Speech and Language Hearing Association).  She also tested depression screening strategies and cognitive behavioral treatment for depressed patients with ovarian cancer (K07CA093512) and head and neck cancer (R03CA108358). Her interest in mobile technologies led to a multi-PI clinical trial testing the efficacy of a remote dehydration monitoring system (CYCORE) in the reduction of hospitalization rates for head and neck cancer patients during radiation (Peterson; R01CA177996). She also co-leads an NSF DARE grant (1929748) to test the effects of haptic feedback on patient engagement with a throat sensor for early detection of swallowing problems after head and neck cancer treatment. Her interest in biobehavioral research led to an observational biomarker study for barriers to adherence (R21DE019954) and a DOD-funded multisite project characterizing biobehavioral factors in long-term versus short-term ovarian cancer survivors.

      Dr. Shinn has led and served on various extramural committees, including the Health Services Research and Quality Improvement education committee for ASCO and the Patient Reported Outcomes working group for the Translational Breast Cancer Research Consortium. She serves on the editorial board for BMC Cancer and has been a scientific reviewer for the Department of Defense Breast Cancer Research Program and NIH. 


      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Tenured, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Tenured, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1998Ohio University, Athens, US, Clinical Psychology, Ph.D
      1996Baylor College of Medicine, Houston, Texas, US, Clinical Psychology, Resident
      1993Ohio University, Athens, Ohio, US, Clinical Psychology, M.S
      1989Amherst College, Amherst, Massachusetts, US, Psychology, BS

      Postgraduate Training

      2000-2004R-25 National Cancer Institute Cancer Prevention Training Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
      1998-2000NIH training grant, National Cancer Institute Postdoctoral Fellowship, The University of Texas - Houston Health Science Center, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Tenure-Track, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2022

      Assistant Professor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2014

      Instructor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2009

      Intramural Institutional Committee Activities

      Member, Cancer Survivorship Research Advisory Workgroup, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Leader, Patient Survey Informatics Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Advanced Breast Cancer Program Steering Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2025

      Member, Breast Center Patient- Reported Outcomes Implementation Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, Faculty Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, Clinical Care Workgroup, PRO working group, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, Advanced Breast Cancer Program Research committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024

      Member, Faculty Search Committee- Psychosocial/ Clinical Psychology Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024

      Member, Advisory Council of Clinical Research Leaders (ACCRL), The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, Data Endurance Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2020

      Member, Head and Neck Cancer Multidisciplinary Research Work Group, The University of Texas MD Anderson Cancer Center, 2019 - 2024

      Ad Hoc Reviewer, MDACC INTEREST Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Chair, Vice Provost Advisory Council (VPAC)- Population Sciences, The University of Texas MD Anderson Cancer Center, 2017 - 2020

      Member, Faculty Search Committee- Psychosocial/ Clinical Psychology Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2020

      Reviewer, Institutional Research Grants - Clinical Study Section, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, MDA Psychologist Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018

      Member, Clinical Care Workgroup, The University of Texas MD Anderson Cancer Center, 2015 - 2024

      Scientific Member, Institutional Review Board 4, The University of Texas MD Anderson Cancer Center, 2015 - 2020

      Member, Faculty Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2022

      Member, Ovarian Cancer Moonshots, The University of Texas MD Anderson Cancer Center, 2011 - 2017

      Member, Survivorship Research Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2014

      Member, Psychosocial, Behavioral and Health Services Research Review Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2013

      Member, Psychosocial, Behavioral and Health Services Research Review Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2009

      Alternate, Institutional Review Board, Psychological, Behavioral and Health Services Research, The University of Texas MD Anderson Cancer Center, 2007

      Extramural Institutional Committee Activities

      Member of the Health Services Research and Quality Improvement Track, Scientific Program Committee, American Society of Clinical Oncology, 2022 - 2023

      Leader, Annual Meeting Education Committee: Health Services Research and Quality Improvement, American Society of Clinical Oncology, 2022 - 2023

      Member, Annual Meeting Education Committee: Health Services Research and Quality Improvement, American Society of Clinical Oncology, 2021 - Present

      Co-Leader, Patient-reported Outcomes Interest Group, Translational Breast Cancer Research Consortium (TBCRC), 2021 - Present

      Committee Member, Patient Reported Outcomes Interest Group, Translational Breast Cancer Research Consortium (TBCRC), 2015 - 2021

      Editorial Activities

      Editorial Board Member, BMC Cancer, 2024 - Present

      Psycho-Oncology Section Editor, Current Breast Cancer Reports, 2016 - 2018

      Honors & Awards

      2016The National Foundation of Swallowing Disorders Award, National Foundation of Swallowing Disorders
      2011Head and Neck Cancer Alliance New Investigator Award, American Speech Language Hearing Association, Division 13
      1990 - 1991Patricia R. Harris Fellowship, Ohio University Clinical Psychology

      Professional Memberships

      American Society of Clinical Oncology (ASCO)

      2020 - Present

      International Society for Research on Internet Interventions (ISRII)

      2018 - Present

      Dysphagia Research Society

      2016 - Present

      Dysphagia Research Society

      2011 - 2012

      American Psychosomatic Society

      2010 - Present

      American Society of Preventive Oncology (ASPO)

      2007

      Society of Behavioral Medicine

      2002 - Present

      American Society of Preventive Oncology (ASPO)

      2000 - 2002

      Selected Presentations & Talks

      Local Presentations

      1. 2026. Treatment Decisions in the Context of Uncertainty: Predicted Benefit of Treatment vs. Predicted Impact on Long-Term QoL. Poster. MDA Cancer Survivorship Conference 2026: Cancer Survivorship Research Grand Rounds: Leveraging AI and Big Data for Survivorship Research. Houston, Texas, US.
      2. 2026. Research Priority Collaboration: Unlocking Insights using Patient Reported Outcomes. Invited. MDA Cancer Survivorship Conference 2026: Cancer Survivorship Research Grand Rounds: Leveraging AI and Big Data for Survivorship Research. Houston, Texas, US.
      3. 2025. Opening Lecture: Metastatic Breast Cancer couples’ retreat. Advanced Breast Cancer Program’s Couples Retreat. Houston, Texas, US.
      4. 2024. Addressing patient uncertainty and existential angst with behavioral interventions. Division of Cancer Prevention Grand Rounds. Houston, Texas, US.
      5. 2022. Using the Persuasive Design Model to Refine a Novel Stimuli-Responsive Polymeric Sensor in Head and Neck Cancer Patients. Conference. Using the Persuasive Design Model to Refine a Novel Stimuli-Responsive Polymeric Sensor in Head and Neck Cancer Patients. Houston, TX, US.
      6. 2018. Enhancing Adherence to Difficult Regimens in Cancer Patients: Evidence-based Approaches and Future Directions. Conference. Enhancing Adherence to Difficult Regimens in Cancer Patients: Evidence-based Approaches and Future Directions. Houston, TX, US.
      7. 2012. Project PREPARE: Impacting adherence and head and neck cancer patient outcomes. Conference. Project PREPARE: Impacting adherence and head and neck cancer patient outcomes. Houston, TX, US.
      8. 2012. Improved swallowing outcomes in head and neck cancer survivors: Initial result from a randomized behavioral trial. Conference. Improved swallowing outcomes in head and neck cancer survivors: Initial result from a randomized behavioral trial. Houston, TX, US.

      Regional Presentations

      1. 2024. Patient engagement with a mobile self-management adherence intervention improves global and emotional swallowing function in throat cancer patients. Conference. UT-Austin & MD Anderson Collaborative Research Summit, US.
      2. 2018. Digital Communication Preferences and Medication Adherence in a Predominantly Hispanic Breast Cancer Survivors. Conference. Digital Communication Preferences and Medication Adherence in a Predominantly Hispanic Breast Cancer Survivors, US.
      3. 2018. Enhancing Adherence to Difficult Regimens in Cancer Patients: Evidence-based Approaches and Future Directions. Conference. Enhancing Adherence to Difficult Regimens in Cancer Patients: Evidence-based Approaches and Future Directions. Houston, US.
      4. 2017. Interactive Patient-centered Website to Prevent Dysphagia in Irradiated Pharyngeal Cancer Patients. Conference. Interactive Patient-centered Website to Prevent Dysphagia in Irradiated Pharyngeal Cancer Patients. Austin, TX, US.
      5. 2015. Media-Rich Mobile Dissemination of a Dysphagia Prevention Program for Head and Neck Cancer Patients During Radiation. Conference. Media-Rich Mobile Dissemination of a Dysphagia Prevention Program for Head and Neck Cancer Patients During Radiation. Austin, TX, US.
      6. 2009. Incidence and risk factors of comorbid cardiac events in oropharynx cancer survivors. Conference. Incidence and risk factors of comorbid cardiac events in oropharynx cancer survivors, US.

      National Presentations

      1. 2021. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time. Conference. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time, US.
      2. 2021. Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention. Conference. Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention. Austin, TX, US.
      3. 2020. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time. Conference. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time, US.
      4. 2019. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Conference. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. San Diego, CA, US.
      5. 2018. Interactive Patient-centered Website to Prevent Dyphagia in Irradiated Pharyngeal CAncer Patients. Conference. 39th Annual Meeting and Scientific Sessions. New Orleans, LA, US.
      6. 2018. Interactive Patient-centered Website to Prevent Dyphagia in Irradiated Pharyngeal Cancer Patients. Conference. Interactive Patient-centered Website to Prevent Dyphagia in Irradiated Pharyngeal Cancer Patients. New York, NY, US.
      7. 2017. Active Living After Breast Cancer: Combining physical activity and survivorship navigation to improve quality of life of breast cancer survivors. Conference. Global Academic Programs Conference 2017. Houston, TX, US.
      8. 2017. Mobile Dissemination of an Efficacious Dysphagia Prevention Program for Head and Neck Cancer Patients during Radiation. Conference. Mobile Dissemination of an Efficacious Dysphagia Prevention Program for Head and Neck Cancer Patients during Radiation. San Diego, CA, US.
      9. 2016. Randomized control trial of a Self-Management adherence intervention in late-stage head and neck cancer. Conference. Randomized control trial of a Self-Management adherence intervention in late-stage head and neck cancer. Washington, DC, US.
      10. 2016. Randomized control trial of a Self-Management adherence intervention for preventive swallowing exercises in late-stage head and neck cancer. Conference. Randomized control trial of a Self-Management adherence intervention for preventive swallowing exercises in late-stage head and neck cancer. Tucson, AZ, US.
      11. 2015. Depression and oropharynx cancer outcome. Conference. Depression and oropharynx cancer outcome. Savannah, GA, US.
      12. 2015. SSRI use and clinical outcomes in epithelial ovarian cancer. Conference. American Psychosomatic Society 73rd Annual Meeting. Savannah, GA, US.
      13. 2014. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Conference. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Bethesda, MD, US.
      14. 2013. Use-oriented basic research: testing change mechanisms in Project PREPARE. NIH. Conference. Use-oriented basic research: testing change mechanisms in Project PREPARE. NIH. Seattle, WA, US.
      15. 2012. PREPARE: Initial Results from a Randomized Intervention Trial. Conference. Oral Presentation at 33rd Annual Meeting of the Society of Behavioral Medicine. New Orleans, LA, US.
      16. 2011. Impact of cardiovascular comorbidity on ovarian cancer outcome. Conference. Oral Presentation at American Psychosomatic Society. San Antonio, TX, US.
      17. 2011. Swallowing exercise regimen: Impact of adherence on outcomes in head and neck cancer. Conference. Oral Presentation Dysphagia Research Society. San Antonio, TX, US.
      18. 2008. Large Preventive Impact of Swallowing Exercises to Long-Term Function in Head and Neck Cancer. Conference. 4th Biennial Cancer Survivorship Research Conference. Bethesda, MD, US.
      19. 2006. Low adherence to preventive swallowing and dental regimens in head and neck cancer survivors in a multidisciplinary cancer center. Conference. Cancer Survivorship: Embracing the Future, National Institutes of Health. Bethesda, MD, US.
      20. 2005. Depression and adherence in head and neck cancer. Conference. Poster Presentation to the Small Grants Grantee Meeting sponsored by NCI and LAF. Bethesda, MD, US.
      21. 2005. An in-home pilot intervention for depression in depressed ovarian cancer patients. Conference. Poster Presentation to the Small Grants Grantee Meeting sponsored by NCI and LAF. Bethesda, MD, US.
      22. 2001. Quality of life and psychological distress in survivors of testis cancer. Conference. Poster presentation at the 22nd Annual Meeting of the Society of Behavioral Science. Seattle, WA, US.
      23. 2001. Total cholesterol concentration and depression in a prospective cohort study. Conference. Oral presentation at the 22nd Annual Meeting of the Society of Behavioral Medicine. Seattle, WA, US.
      24. 2001. Depressive symptoms and health behaviors in testicular cancer survivors. Conference. Poster presentation at the 22nd Annual Meeting of the Society of Behavioral Medicine. Seattle, WA, US.
      25. 2001. Psychological distress and long-term toxicity in testicular cancer survivors. Conference. Poster presentation at the 22nd Annual Meeting of the Society of Behavioral Medicine. Seattle, WA, US.
      26. 2001. Health behaviors in testicular cancer survivors. Conference. Poster presentation at American Society of Behavioral Medicine. New Orleans, LA, US.
      27. 1999. Depression and anxiety as psychosocial precursors for elevated blood pressure. Conference. Oral Presentation: Society of Behavioral Science, US.
      28. 1993. Diabetes-induced alterations in 5-HT receptor subtype activation. Conference. Published abstract presented at Society for Neuroscience annual meeting. Washington, DC, US.

      International Presentations

      1. 2025. Patient adherence to preventive swallowing exercises with a digital self-management intervention in community settings for head and neck cancer. Conference. International Congress of Behavioral Medicine (ICBM) 2025. Vienna, AT.
      2. 2023. Impact of a web-based self-management adherence intervention on global and emotional swallowing function in throat cancer patients. Conference. Impact of a web-based self-management adherence intervention on global and emotional swallowing function in throat cancer patients, IT.
      3. 2023. Making Real-World Big Data Work for Us: Integration, Quality Analysis and Insights, Discussant. Conference. Research and Quality Improvement Poster Discussion Session. Chicago, US.
      4. 2021. Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05). Poster. San Antonio Breast Cancer Symposium (SABCS). San Antonio, US.
      5. 2021. Adherence with Adjuvant Endocrine Therapy with or without Palbociclib in the PALLAS Trial. Conference. San Antonio Breast Cancer Symposium (SABCS). San Antonio, US.
      6. 2019. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Conference. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Auckland, NZ.
      7. 2014. Promoting adherence to preventive swallowing exercises in head and neck cancer patients: Improved swallowing 1 year post-radiation. Conference. Poster presentation at the 4th Annual Meeting of Global Academic Programs (GAP) Conference. Seoul, KR.
      8. 2013. Improving Outcomes in Head and Neck Cancers: The CYCORE Project. Conference. Improving Outcomes in Head and Neck Cancers: The CYCORE Project. Chicago, US.

      Formal Peers

      1. 2021. Applying mobile technologies and complex regulatory modeling to enhance adherence behaviors in cancer patients. Invited. Athens, OH, US.
      2. 2014. CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research. Invited. San Diego, CA, US.
      3. 2014. Clinical outcomes in cancer survivorship: the impact of adherence. Invited. Charlotte, SC, US.
      4. 2013. Clinical outcomes in cancer survivorship: the impact of depression and adherence. Invited. Columbus, OH, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - 2029
      Title:Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      ID:HT94252510398
      Date: 2024 - 2029
      Title:Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer
      Funding Source:Indiana University, NIH
      Role:Co-I
      ID:1 R01CA289486-01
      Date: 2015 - 2020
      Title:Media-Rich mobile dissemination of a dysphagia prevention program for head and neck cancer patients during radiation
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:PP150077

      Selected Publications

      Peer-Reviewed Articles

      1. Shaitelman SF, Savitri K, Margishvili RG, Heather L, Yu S, Vicente V, Margaret JH, Manickam M, Benjamin S, Karen H, Lee Belinda M, Shinn EH, Symmans WF, Wendy W, Pulfer MM, Rae GC, Buzdar AU, Puneet S, Nina T, Mark KH. Definitive stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: a prospective, phase II trial. RADONC. e-Pub 2026.
      2. Wang Y, Shinn EH, Wu Y, González-Domínguez N, Boruff J, Levis B, Cuijpers P, Gilbody S, Harel D, Loannidis J, Markham S, Patten S, Vigod S, Ziegelstein R, Benedetti A, Thombs B. Minimal Detectable Change of the Patient Health Questionnaire-9 (PHQ-9), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-2 (PHQ-2): Individual Patient Data Meta-Analysis. The BMJ. e-Pub 2026.
      3. Mosher CE, Shinn EH, Addington EL, Wu W, Bricker JB, Helft PR, Turk AA, Vater LB, Masood A, Jalal SI, Loehrer PJ, Champion VL, Johns S. Protocol of a randomized trial of acceptance and commitment therapy for patient fatigue interference and caregiver burden in advanced gastrointestinal cancer. Contemporary Clinical Trials 160, 2026. e-Pub 2026. PMID: 41314597.
      4. Caston NE, Deng L, Williams CP, Levitan EB, Azuero A, Griffin R, Smith KL, Wolff AC, Melisko ME, Shinn EH, Gallagher KD, Angove R, Wheeler SB, Rocque GB. System-Level Transformations to Increase Patient Participation in Clinical Trials. JCO Oncology Practice 21(10):1502-1511, 2025. e-Pub 2025. PMID: 40080789.
      5. Caston, NE, Deng, L, Williams, CP, Levitan, EB, Azuero, A, Griffin, R, Smith, KL, Wolff, AC, Melisko, ME, Shinn, EH, Gallagher, KD, Angove, R, Wheeler, SB, Rocque, GB. Understanding Associations Between Patient-Level Factors and Participation in a Breast Cancer Clinical Trial. Cancer medicine 14(16), 2025. e-Pub 2025. PMID: 40836443.
      6. Shinn, EH, Zahrieh, D, DeMichele, A, Zdenkowski, N, Lemieux, J, Mao, J, Bjelic-Radisic, V, Naughton, MM, Pfeiler, G, Gelmon, K, Balko, JM, Egle, D, Zoppoli, G, Traina, T, Jimenez, MM, Novoa, SA, Haddad, T, Chan, A, Ring, A, Wolff, AC, Symmans, WF, Ponce Lorenzo, J, Sabanathan, D, Burstein, HJ, Nowecki, Z, Pristauz-Telsnigg, G, Brufsky, AM, Bellet, M, Foukakis, T, Novik, Y, Rubovszky, G, Singer, CF, Muehlbacher, K, Filho, OM, Goulioti, T, Law, E, Partridge, AH, Carey, LA, Zoroufy, A, Hlauschek, D, Fesl, C, Mayer, E, Gnant, M. Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer. Breast Cancer Research and Treatment 211(2):385-397, 2025. e-Pub 2025. PMID: 40140172.
      7. Naughton MJ, Zahrieh D, Gnant M, Zdenkowski N, Lemieux J, Mao JJ, Bjelic-Radisic V, Shinn EH, Balic M, Thomssen C, Meisel JL, Ruiz GM, Loibl S, Isaacs C, Cameron D, Henao F, Goetz MP, Singer CF, Werutsky G, Rugo H, Vetter, M, Tseng, LM, Miller, KD, Fitzal, F, Gil Gil, JM, Park, H, Linderholm, B, Bajetta, E, Dayao, Z, Prat, A, Ehrhardt, K, Metzger-Filho, O, Arahmani, A, Law, E, Partridge, AH, Carey, LA, Zoroufy, A, Dueck, A, O'Brien, P, Hlauschek, D, DeMichele, A, Mayer, E. Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109). ESMO Open 10(6), 2025. e-Pub 2025. PMID: 40472660.
      8. Levis B, Bhandari PM, Neupane D, Fan S, Sun Y, Thombs BD, Benedetti A, PHQ Group DSD. Variability and bias in optimal cutoffs and accuracy estimates due to data-driven cutoff selection: Simulation study using data from 100 PHQ-9 accuracy studies. JAMA Network Open 54(4):729-37, 2024. e-Pub 2024. PMID: 18258670.
      9. Levis, B, Bhandari, PM, Neupane, D, Fan, S, Sun, Y, He, C, Wu, Y, Krishnan, A, Negeri, Z, Imran, M, Rice, DB, Riehm, KE, Azar, M, Levis, AW, Boruff, J, Cuijpers, P, Gilbody, S, Ioannidis, JP, Kloda, LA, Patten, SB, Ziegelstein, RC, Harel, D, Takwoingi, Y, Markham, S, Alamri, SH, Amtmann, D, Arroll, B, Ayalon, L, Baradaran, HR, Beraldi, A, Bernstein, CN, Bhana, A, Bombardier, CH, Buji, RI, Butterworth, P, Carter, G, Chagas, MH, Chan, JC, Chan, LF, Chibanda, D, Clover, K, Conway, A, Conwell, Y, Daray, FM, de Man-van Ginkel, JM, Fann, J, Fischer, FH, Field, S, R. W. Fisher, J, Shinn, EH. Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool. JAMA Network Open 7(11):e2429630, 2024. e-Pub 2024. PMID: 39576645.
      10. Shinn EH, Garden AS, Chen M, Basen-Engquist K, Fellman B, Hutcheson K, Morrison WH, Peterson S, Li L. Self-management intervention improves patient adherence to swallowing exercises during radiation for head and neck cancer. Head Neck 46(11):2878-2889, 2024. e-Pub 2024. PMID: 38873861.
      11. Chopra D, Shinn EH, Teo I, Bordes MC, Reece G, Liu J, Markey M, Weber R, Fingeret M. A cognitive behavioral therapy-based intervention to address body image in patients with facial cancers: Results from a randomized controlled trial. Palliat Support Care 22(5):1-8, 2024. e-Pub 2024. PMID: 36994832.
      12. Harel, D, Wu, Y, Levis, B, Fan, S, Sun, Y, Xu, M, Rice, DB, Boruff, J, Markham, S, Ioannidis, JP, Takwoingi, Y, Patten, SB, Ziegelstein, RC, Cuijpers, P, Gilbody, S, Vigod, SN, Akena, D, Benedetti, A, Thombs, BD, Azar, M, Bhandari, PM, Chiovitti, MJ, He, C, Imran, M, Krishnan, A, Negeri, Z, Neupane, D, Riehm, KE, Yan, XW, Kloda, LA, Henry, M, Ismail, Z, Loiselle, CG, Mitchell, ND, Al-Adawi, S, Alvarado, R, Amtmann, D, Arroll, B, Ayalon, L, Baradaran, HR, Barnes, J, Beck, KR, Beck, CT, Bernstein, CN, Bindt, C, Bombardier, CH, Boye, B, Büel-Drabe, N, Buji, RI, Shinn, EH. Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression – Depression subscale scores by administration mode. Journal of Affective Disorders 361:674-683, 2024. e-Pub 2024. PMID: 38908554.
      13. Ohannesian N, Mallick MS, He J, Qiao Y, Li N, Shaitelman SF, Tang C, Shinn EH, Hofstetter WL, Goltsov A, Hassan MM, Hunt KK, Lin SH, Shih WC. Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Commun Med (Lond) 4(1):100, 2024. e-Pub 2024. PMID: 38796532.
      14. Smith KL, Mead-Harvey C, Mazza GL, Shinn E, Frank ES, Melisko ME, Eaton C, Salamone JM, Pollastro T, Spears PA, Wolff AC, Rocque GB. The TBCRC 057 Survey about willingness to participate in cancer clinical trials during the pandemic: Using the pandemic experience to rethink clinical research moving forward. Cancer Medicine 13(5), 2024. e-Pub 2024. PMID: 38466037.
      15. Shinn E, Garden, A S, Peterson, S K, Leupi, D J, Chen, M, Blau, R, Becerra, L, Rafeedi, T, Ramirez, J, Rodriquez, D, VanFossen, F, Zehner, S, Mercier, P P, Wang, J, Hutcheson, K, Hanna, E, Lipomi, D J. Iterative patient testing of a stimuli-responsive swallowing activity sensor to promote extended user engagement during the first year after radiation: Multiphase remote and in-person observational cohort study. JMIR Cancer 10(e47359), 2024. e-Pub 2024. PMID: 38416544.
      16. Saab RH, Salvo G, Gonzales NR, Munsell MF, Shinn E, Jhingran A, Bhosale P, Ramalingam P, Frumovitz M. Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: a NeCTuR study. Gynecol Oncol 177:95-102, 2023. e-Pub 2023. PMID: 37657194.
      17. Harel D, Levis B, Sun Y, Fischer F, Ioannidis JPA, Cuijpers P, Patten SB, Ziegelstein RC, Markham S, Benedetti A, Thombs BD, PHQ Collaboration DSDD. External validation of a shortened screening tool using individual participant data meta-analysis. Methods 204:300-311, 2022. e-Pub 2022. PMID: 34780986.
      18. Shinn EH, Busch BE, Jasemi N, Lyman CA, Toole JT, Richman SC, Symmans WF, Chavez-MacGregor M, Peterson SK, Broderick G. Network modeling of complex time-dependent changes in patient adherence to adjuvant endocrine treatment in ER+ breast cancer. Front Psychol 13:856813, 2022. e-Pub 2022. PMID: 35903747.
      19. Tami-Maury IM, Liao Y, Rangel ML, Gatus LA, Shinn EH, Alexander A, Basen-Engquist K. Active Living After Cancer: Adaptation and evaluation of a community-based physical activity program for minority and medically underserved breast cancer survivors. Cancer 128(2):353-363, 2022. e-Pub 2022. PMID: 34554567.
      20. Ketcher D, Lutgendorf SK, Leighton S, Matzo M, Carter J, Peddireddy A, Karlan BY, Tew WP, Sood AK, Shinn EH. Attributions of survival and methods of coping of long-term ovarian cancer survivors: A qualitative study. BMC Womens Health 21(1):376, 2021. e-Pub 2021. PMID: 34711227.
      21. Fischer F, Levis B, Falk C, Sun Y, Ioannidis JPA, Cuijpers P, Shrier I, Benedetti A, Thombs BD, PHQ Collaboration DSD. Comparison of different scoring methods based on latent variable models of the PHQ-9: an individual participant data meta-analysis. Psychol Med:1-12. e-Pub 2021. PMID: 33612144.
      22. Peterson SK, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Shinn EH, Martch SL, Beadle BM, Garden AS, Farcas E, Brandon Gunn G, Fuller CD, Morrison WH, Rosenthal DI, Phan J, Eng C, Cinciripini PM, Karam-Hage MA, Camero Garcia M, Patrick K. Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention. AMIA Annu Symp Proc 2021:979-988, 2021. e-Pub 2021. PMID: 35308916.
      23. Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD. Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom 90(1):28-40, 2021. e-Pub 2021. PMID: 32814337.
      24. Levis B, Benedetti A, Ioannidis JPA, Sun Y, Negeri Z, He C, Wu Y, Krishnan A, Bhandari PM, Neupane D, Imran M, Rice DB, Riehm KE, Saadat N, Azar M, Boruff J, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Alamri SH, Amtmann D, Ayalon L, Baradaran HR, Beraldi A, Bernstein CN, Bhana A, Bombardier CH, Carter G, Chagas MH, Chibanda D, Clover K, Conwell Y, Diez-Quevedo C, Fann JR, Fischer FH, Gholizadeh L, Gibson LJ, Green EP, Greeno CG, Hall BJ, Haroz EE, Ismail K, Jetté N, Khamseh ME, Kwan Y, Lara MA, Liu SI, Loureiro SR, Löwe B, Marrie RA, Marsh L, McGuire A, Muramatsu K, Navarrete L, Osório FL, Petersen I, Picardi A, Pugh SL, Quinn TJ, Rooney AG, Shinn EH, Sidebottom A, Spangenberg L, Tan PLL, Taylor-Rowan M, Turner A, van Weert HC, Vöhringer PA, Wagner LI, White J, Winkley K, Thombs BD. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol 122:115-128.e1, 2020. e-Pub 2020. PMID: 32105798.
      25. Bowen DJ, Shinn EH, Gregrowski S, Kimmick G, Dominici LS, Frank ES, Smith KL, Rocque G, Ruddy KJ, Pollastro T, Melisko M, Ballinger TJ, Fayanju OM, Wolff AC. Patient-Reported Outcomes in the Translational Breast Cancer Research Consortium. Cancer 126(5):922-930, 2020. e-Pub 2020. PMID: 31743427.
      26. Peres LC, Sinha S, Townsend MK, Fridley BL, Karlan BY, Lutgendorf SK, Shinn E, Sood AK, Tworoger SS. Predictors of survival trajectories among women with epithelial ovarian cancer. Gynecol Oncol 156(2):459-466, 2020. e-Pub 2020. PMID: 31839342.
      27. Shinn EH, Jensen K, McLaughlin J, Garden AS, Fellman BM, Liang L, Peterson SK. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Internet Interv 18:100289, 2019. e-Pub 2019. PMID: 31890636.
      28. Shinn EH, Broderick G, Fellman B, Johnson A, Wieland E, Moulder S, Symmans WF. Simulating Time-Dependent Patterns of Nonadherence by Patients With Breast Cancer to Adjuvant Oral Endocrine Therapy. JCO Clin Cancer Inform 3:1-9, 2019. e-Pub 2019. PMID: 31002563.
      29. Ramírez J, Rodriquez D, Qiao F, Warchall J, Rye J, Aklile E, S-C Chiang A, Marin BC, Mercier PP, Cheng CK, Hutcheson KA, Shinn EH, Lipomi DJ. Metallic Nanoislands on Graphene for Monitoring Swallowing Activity in Head and Neck Cancer Patients. ACS Nano 12(6):5913-5922, 2018. e-Pub 2018. PMID: 29874030.
      30. Lutgendorf SK, Shinn E, Carter J, Leighton S, Baggerly K, Guindani M, Fellman B, Matzo M, Slavich GM, Goodman MT, Tew W, Lester J, Moore KM, Karlan BY, Levine DA, Sood AK. Quality of life among long-term survivors of advanced stage ovarian cancer: a cross-sectional approach. Gynecol Oncol 146(1):101-108, 2017. e-Pub 2017. PMID: 28527672.
      31. Shinn EH, Valentine A, Baum G, Carmack C, Kilgore K, Bodurka D, Basen-Engquist K. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol 145(3):562-568, 2017. e-Pub 2017. PMID: 28400146.
      32. Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, Sood AK, Lutgendorf SK. SSRI use and clinical outcomes in epithelial ovarian cancer. Oncotarget 7(22):33179-91, 2016. e-Pub 2016. PMID: 27121207.
      33. Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS. Depression and Oropharynx Cancer Outcome. Psychosom Med 78(1):38-48, 2016. e-Pub 2016. PMID: 26632757.
      34. Peterson SK, Shinn EH, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Baru C, Krueger IH, Farcas E, Rios P, Garden AS, Beadle BM, Lin K, Yan Y, Martch SL, Patrick K. Identifying Early Dehydration Risk With Home-Based Sensors During Radiation Treatment: A Feasibility Study on Patients With Head and Neck Cancer. J Natl Cancer Inst Monogr 2013(47):162-168, 2013. e-Pub 2013. PMID: 24395986.
      35. Shinn EH, Basen-Engquist K, Baum G, Steen S, Bauman RF, Morrison W, Garden AS, Sheil C, Kilgore K, Hutcheson KA, Barringer D, Yuan Y, Lewin JS. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Head Neck 35(12):1707-12, 2013. e-Pub 2013. PMID: 24142523.
      36. Hutcheson KA, Bhayani MK, Beadle BM, Gold KA, Shinn EH, Lai SY, Lewin J. Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it. JAMA Otolaryngol Head Neck Surg 139(11):1127-34, 2013. e-Pub 2013. PMID: 24051544.
      37. Shinn EH, Lenihan DJ, Urbauer DL, Basen-Engquist KM, Valentine A, Palmero L, Woods ML, Patel P, Nick AM, Shahzad MM, Stone RL, Golden A, Atkinson E, Lutgendorf SK, Sood AK. Impact of cardiovascular comorbidity on ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 22(11):2102-9, 2013. e-Pub 2013. PMID: 24045927.
      38. Shinn E, Qazi U, Gera S, Brodovsky J, Simpson J, Follen M, Basen-Engquist K, Macaulay C. Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study. Gend Med 9(1 Suppl):S67-77; quiz 77.e1-6, 2012. e-Pub 2012. PMID: 22340642.
      39. Buys TP, Cantor SB, Guillaud M, Adler-Storthz K, Cox DD, Okolo C, Arulogon O, Oladepo O, Basen-Engquist K, Shinn E, Yamal JM, Beck JR, Scheurer ME, Van Niekerk D, Malpica A, Matisic J, Staerkel G, Atkinson EN, Bidaut L, Lane P, Benedet JL, Miller D, Ehlen T, Price R, Adewole IF, Macaulay C, Follen M. Optical Technologies and Molecular Imaging for Cervical Neoplasia: A Program Project Update. Gend Med 9(1 Suppl):S7-24, 2012. e-Pub 2012. PMID: 21944317.
      40. Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, Macaulay C, Follen M. Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer 128(5):1151-68, 2011. e-Pub 2011. PMID: 20830707.
      41. Shinn EH, Swartz RJ, Thornton BB, Spiess PE, Pisters LL, Basen-Engquist KM. Testis cancer survivors’ health behaviors: comparison with age-matched relative and demographically-matched population controls. J Clin Oncol 28(13):2274-2279, 2010. e-Pub 2010. PMID: 20368572.
      42. Shinn EH, Taylor CL, Kilgore K, Valentine A, Bodurka DC, Kavanagh J, Sood A, Li Y, Basen-Engquist K. Associations with Worry about Dying and Hopelessness in Ambulatory Ovarian Cancer Patients. Palliat Support Care 7(3):299-306, 2009. e-Pub 2009. PMID: 19788771.
      43. Lamkin DM, Spitz DR, Shahzad MM, Zimmerman B, Lenihan DJ, Degeest K, Lubaroff DM, Shinn EH, Sood AK, Lutgendorf SK. Glucose as a prognostic factor in ovarian carcinoma. Cancer 115(5):1021-27, 2009. e-Pub 2009. PMID: 19156916.
      44. Basen-Engquist K, Hughes D, Perkins H, Shinn E, Taylor CC. Dimensions of physical activity and their relationship to physical and emotional symptoms. J Cancer Surviv 2(4):253-61, 2008. e-Pub 2008. PMID: 18923906.
      45. Shinn EH, Basen-Engquist K, Thornton B, Spiess PE, Pisters L. Health behaviors and depressive symptoms in testicular cancer survivors. Urology 69(4):748-53, 2007. e-Pub 2007. PMID: 17445663.
      46. Basen-Engquist K, Fouladi RT, Cantor SB, Shinn E, Sui D, Sharman M, Follen M. Patient assessment of tests to detect cervical cancer. Int J Technol Assess Health Care 23(2):240-247, 2007. e-Pub 2007. PMID: 17493310.
      47. Basen-Engquist K, Taylor CL, Rosenblum C, Smith MA, Shinn EH, Greisinger A, Gregg X, Massey P, Valero V, Rivera E. Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 64(1-3):225-34, 2006. e-Pub 2006. PMID: 16843633.
      48. Shinn E, Basen-Engquist K, Le T, Hansis-Diarte A, Bostic D, Martinez-Cross J, Santos A, Follen M. Distress after an abnormal Pap smear result: scale development and psychometric validation. Prev Med 39(2):404-12, 2004. e-Pub 2004. PMID: 15226053.
      49. Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22(5):881-9, 2004. e-Pub 2004. PMID: 14990644.
      50. Basen-Engquist K, Shinn EH, Warneke C, de Moor C, Le T, Richards-Kortum R, Follen M. Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection. Am J Obstet Gynecol 189(4):1136-42, 2003. e-Pub 2003. PMID: 14586367.
      51. Shinn EH, Poston WS, Kimball KT, St Jeor ST, Foreyt JP. Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens 14(7 Pt 1):660-4, 2001. e-Pub 2001. PMID: 11482304.
      52. Peters R, Kelder S, Ross M, McAlister A, Meshack A, Lewis S, Baumler E, Shinn E. Project Alpha: a culturally appropriate approach to adolescent male sex education. Venereology 13(2):57-62, 2000. e-Pub 2000.
      53. Epstein S, Lipson A, Holstein C, Huh E. Irrational reactions to negative outcomes: evidence for two conceptual systems. J Pers Soc Psychol 62(2):328-39, 1992. e-Pub 1992. PMID: 1556663.

      Invited Articles

      1. Shinn E, Le T, Gallegos J, Basen-Engquist K. A pilot analysis of multispectral digital colposcopy for women with high-grade squamous intraepithelial lesion (HGSIL) Pap smear results. Gynecol Oncol 107(1 Suppl 1):S83-5, 2007. e-Pub 2007. PMID: 17822747.
      2. Shinn E, Basen-Engquist K, Crain B, Follen M. A theory-aided dissemination strategy for emerging technologies in cervical cancer screening. Gynecol Oncol 107(1 Supp 1):S 35-9, 2007. e-Pub 2007. PMID: 17870151.
      3. Shinn E. Commentary on Yan LL, Liu K, Mathews KA, et al, Cohort study finds that impatience and hostility in young adults are linked with long term risk of hypertension. JAMA 2003. 290: 2138-2148. Evidence-based Cardiovascular Medicine 8(1):36-37, 2004. e-Pub 2004. PMID: 16379888.
      4. Shinn E, Basen-Engquist K. Guest editor commentary on Alderman AK, Wilkins EG, Lowery JC, et al. Determinants of patient satisfaction in postmastectomy breast reconstruction. Plast Reconstr Surg 106:769-776, Sep 2000. Breast Diseases, a Yearbook Quarterly 12:236-237, 2001. e-Pub 2001.

      Review Articles

      1. Rafeedi, T, Abdal, A, Polat, B, Hutcheson, KA, Shinn, EH, Lipomi, DJ. Wearable, epidermal devices for assessment of swallowing function. npj Flexible Electronics 7(1), 2023. e-Pub 2023.
      2. Negeri ZF, Levis B, Sun Y, He C, Krishnan A, Wu Y, Bhandari PM, Neupane D, Brehaut E, Benedetti A, Thombs BD, PHQ Group DSD. Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ 375:n2183, 2021. e-Pub 2021. PMID: 34610915.
      3. Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari PM, Neupane D, Imran M, Brehaut E, Negeri Z, Fischer FH, Benedetti A, Thombs BD, PHQ Collaboration DSD, Che L, Levis A, Riehm K, Saadat N, Azar M, Rice D, Boruff J, Kloda L, Cuijpers P, Gilbody S, Ioannidis J, McMillan D, Patten S, Shrier I, Ziegelstein R, Moore A, Akena D, Amtmann D, Arroll B, Ayalon L, Baradaran H, Beraldi A, Bernstein C, Bhana A, Bombardier C, Buji RI, Butterworth P, Carter G, Chagas M, Chan J, Chan LF, Chibanda D, Cholera R, Clover K, Conway A, Conwell Y, Daray F, de Man-van Ginkel J, Delgadillo J, Diez-Quevedo C, Fann J, Field S, Fisher J, Fung D, Garman E, Gelaye B, Gholizadeh L, Gibson L, Goodyear-Smith F, Green E, Greeno C, Hall B, Hampel P, Hantsoo L, Haroz E, Harter M, Hegerl U, Hides L, Hobfoll S, Honikman S, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jeon HJ, Jetté N, Khamseh M, Kiely K, Kohler S, Kohrt B, Kwan Y, Lamers F, Asunción Lara M, Levin-Aspenson H, Lino V, Liu SI, Lotrakul M, Loureiro S, Löwe B, Luitel N, Lund C, Marrie RA, Marsh L, Marx B, McGuire A, Mohd Sidik S, Munhoz T, Muramatsu K, Nakku J, Navarrete L, Osório F, Patel V, Pence B, Persoons P, Petersen I, Picardi A, Pugh S, Quinn T, Rancans E, Rathod S, Reuter K, Roch S, Rooney A, Rowe H, Santos I, Schram M, Shaaban J, Shinn E, Sidebottom A, Simning A, Spangenberg L, Stafford L, Sung S, Suzuki K, Swartz R, Tan PLL, Taylor-Rowan M, Tran T, Turner A, van der Feltz-Cornelis C, van Heyningen T, van Weert H, Wagner L, Li Wang J, White J, Winkley K, Wynter K, Yamada M, Zhi Zeng Q, Zhang Y. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA 323(22):2290-2300, 2020. e-Pub 2020. PMID: 32515813.

      Professional Educational Materials

      1. Shinn E. Project PREPARE Intervention Manual: Patients Radiation Experiences: Preparation, Adherence, Rehabilitation, Exercises, 2008.

      Other Articles

      1. Shinn, EH, Zahrieh, D, DeMichele, A, Zdenkowski, N, Lemieux, J, Mao, J, Bjelic-Radisic, V, Naughton, MM, Pfeiler, G, Gelmon, K, Balko, JM, Egle, D, Zoppoli, G, Traina, T, Jimenez, MM, Novoa, SA, Haddad, T, Chan, A, Ring, A, Wolff, AC, Symmans, WF, Lorenzo, JP, Sabanathan, D, Burstein, HJ, Nowecki, Z, Pristauz-Telsnigg, G, Brufsky, AM, Bellet, M, Foukakis, T, Novik, Y, Rubovszky, G, Singer, CF, Muehlbacher, K, Filho, OM, Goulioti, T, Law, E, Partridge, AH, Carey, LA, Zoroufy, A, Hlauschek, D, Fesl, C, Mayer, E, Gnant, M Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer (Breast Cancer Research and Treatment, (2025), 211, 2, (385-397), 10.1007/s10549-025-07653-2). Breast Cancer Research and Treatment 216(2), 2026. PMID: 41706231.
      2. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC Correction to. Communications Medicine 4(1), 2024. PMID: 38942807.
      3. Shinn E Adherence to Swallowing Exercises in the Prevention of Radiation-Related Dysphagia. News from SPOHNC, 2015.
      4. Shinn E, Poston C Why we are overweight: Genes vs. Lifestyle. Healthology.Com [On-line], 1998.

      Editorials

      1. Bradford A, Shinn E. Incorporating Patient Perspectives and Priorities into Clinical Trial Design. Commentary on “Endpoints in clinical trials: what do patients consider important? A survey of the Ovarian Cancer National Alliance". Gynecol Oncol 140(2):191-2, 2016. PMID: 26802549.

      Abstracts

      1. Phillips S, Shinn EH, Garden AS, Beadle BM, Camero M, Baum G, Shete S, Farcas E, Patrick K, Peterson SK. Factors associated with adherence to remote patient monitoring for early detection of dehydration risk during radiation treatment for head and neck cancer. Journal of Clinical Oncology 40(16 Supplement):6076-6076, 2022. e-Pub 2022.
      2. Smith KL, Mazza, GL, Mead-Harvey C, Shinn EH, Frank ES, Melisko ME, Eaton C, Salamone JM, Pollastro T, Spears P, Wolff AC, Rocque GB. TBCRC 057: An online survey about anxiety and willingness to participate in breast cancer clinical trials during the COVID-19 pandemic. Journal of Clinical Oncology 40(16 Supplement):1564-1564, 2022. e-Pub 2022.
      3. Shinn E, Broderick G, Lyman C, Symmans F, Toole T. Modeling breast cancer patient adherence trajectories by combining decisional network models and qualitative analysis. Annals of Behavioral Medicine 56(Supp 1):S399, 2022. e-Pub 2022.
      4. Naughton MJ, Zahrieh D, Gnant M, Zdenkowski N, Lemieux J, Mao JJ, Bjelic-Radisic V, Shinn E, Balic M, Thomssen C, Neisel J, Ruiz-Echarri M, Loibl S, Isaacs C, Cameron D, Carrasco FMH, Goetz M, Wette V, Werutsky G, Rugo H, Vetter M, L-M T, Miller K, Fitzal F, Gil JM, Park H, Linderholm B, Bajetta E, Dayao Z, Prat A, Ehrhardt K, Metzger O, Arahmani A, Law E, Partridge A, Carey L, Zoroufy A, Dueck A, Hlauschek D, DeMichele A, Mayer E. Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05). Cancer Res 82(4 Supplement):P4-10-01, 2022. e-Pub 2022.
      5. Shinn E, Zahrieh D, DeMichele A, Zdenkowski N, Lemieux J, Mao J, Bjelic-Radisic V, Naughton M, Pfeiler G, Gelmon K, Mayer I, Egle D, Zoppoli G, Traina T, Jiménez MM, Novoa SA, Haddad T, Chan A, Ring AE, Wolff A, Lorenzo JJP, Sabanathan D, Burstein H, Nowecki ZI, Pristauz-Telsnigg G, Brufsky A, Bellet-Ezquerra M, Foukakis T, Novik Y, Rubovszky G, Muehlbacher K, Metzger O, Goulioti T, Law E, Partridge A, Carey L, Zoroufy A, Hlauschek D, Fesl C, Mayer E, Gnant M. Adherence with Adjuvant Endocrine Therapy with or without Palbociclib in the PALLAS Trial. Cancer Research 82(4 Supplement):P4-12, 2022. e-Pub 2022.
      6. Lyman C, Shinn E, Busch B, Toole T, Richman S, Broderick G. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time. Annals of Behavioral Medicine 55(Suppl 1):S319, 2021. e-Pub 2021.
      7. Shinn E, Mclaughlin J, Kamunyo EW, Peterson SK, Garden AS, Jensen K. Interactive Website for Head and Neck Cancer Patients: Adherence and Coping Program to Prevent Dysphagia After Radiation. Annals of Behavioral Medicine 54(Suppl 1):S584, 2020. e-Pub 2020.
      8. Lyman C, Shinn E, Busch B, Toole T, Richman S, Broderick G. Modeling breast cancer patient, communication and treatment factors in discontinuation of daily adjuvant treatment over time. TACCSTER 2020 Proceedings, University of Texas at Austin Texas Scholar Works, 2020. e-Pub 2020.
      9. Peterson SK, Garden AS, Shinn EH, Shete S, Martch S, Camero M, Baum G, Farcas E, Lin K, Raab F, Nandigam V, Yan Y, Ferrarotto R, Godino J, Patrick K, Beadle BM. Using mobile and sensor technology to identify early dehydration risk in head and neck cancer patients undergoing radiation treatment: Impact on symptoms. Journal of Clinical Oncology 36(15 suppl):6063, 2018. e-Pub 2018.
      10. Shinn E, McLaughlin J, Trevino-Whitaker RA, Kamunyo EW. Interactive Patient-Centered Website to Prevent Dysphagia in Irradiated Pharyngeal Cancer Patients. Annals of Behavioral Medicine 52(Suppl 1):S488, 2018. e-Pub 2018.
      11. Shinn E. Mobile Dissemination of an Efficacious Dysphagia Prevention Program for Head and Neck Cancer Patients During Radiation. Annals of Behavioral Medicine 51(Suppl 1):S2423, 2017. e-Pub 2017.
      12. Shinn E, Carmack C, Kilgore K, Valentine AD, Basen-Engquist K. Comparison of the Diagnostic Accuracy of Four Brief Depression Screening Instruments in Ovarian Cancer Patients. Annals of Behavioral Medicine 51(Suppl 1):S1193, 2017. e-Pub 2017.
      13. Montealegre JR, Scheurer M, Shinn EH, Carrillo T, Mulla Z, Follen M, Basen-Engquist. Racial/ethnic variation in psychological distress following an abnormal Pap test. Cancer Epidemiol Biomarkers Prev 25(3 suppl):Abstract nr C17, 2016. e-Pub 2016.
      14. Peterson SK, Shinn EH, Garden AS, Patrick K, Shete S, Shen C, Martch SL, Farcas E, Lin K, Raab F, Asomaning N, Christie I, Nandigam V, Chen T, Yan Y, Beadle BM. Identifying dehydration risk in head and neck cancer patients undergoing radiation therapy using remote, sensor-based monitoring: A randomized controlled trial. Journal of Clinical Oncology 34(3 suppl):152, 2016. e-Pub 2016.
      15. Shinn E, Garden AS, Lewin JS, Gillenwater AM, Hutcheson KA, Basen-Engquist K, Barringer D, Li L, Chen M, Alvarez CP. Randomized Control Trial of a Self-Management Adherence Intervention in Late-Stage Head and Neck Cancer. Annals of Behavioral Medicine 50(Suppl 1):S119, 2016. e-Pub 2016.
      16. Peterson SK, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Shinn EH, Martch SL, Farcas E, Baru C, Krueger IH, Garden AS, Beadle BM, Eng C, Cinciripini PM, Karam-Hage MA, Gunn GB, Fuller CD, Morrison WH, Rosenthal DI, Phan J, Patrick K. Feasibility of using home-based mobile sensors for remote patient monitoring in cancer care and prevention. J Clin Oncol 32(suppl):5s, 2014. e-Pub 2014.
      17. Shinn E, Coyne J, Sheil C, Lewin J, Garden A, Alvarez C, Basen-Engquist K. PREPARE: Initial results from a randomized intervention trial. Society of Behavioral Medicine, 2012. e-Pub 2012.
      18. Shinn E, Baum G, Hutcheson K, Barringer D, Alvarez C, Lewin J. Swallowing exercise regimen: Impact of adherence on outcomes in head and neck cancer. Dysphagia Research Society 26(4):443, 2011. e-Pub 2011.
      19. Shinn E, Lewin J, Yuan Y, Carmack Taylor C, Morrison W, Garden A, Rosenthal D, Basen-Engquist K. Large Preventive Impact of Swallowing Exercises to Long-Term Function in Head and Neck Cancer. 4th Biennial Cancer Survivorship Research Conference, 2008. e-Pub 2008.
      20. Shinn E, Carmack Taylor C, Chambers M, Lewin J, Morrison W, Schaffner J, Campbell J, Parkhurst J, Basen-Engquist K. Low adherence to preventive swallowing and dental regimens in head and neck cancer survivors in a multidisciplinary cancer center. Cancer Survivorship: Embracing the Future, National Institutes of Health Competitive poster presentation, 2006. e-Pub 2006.
      21. Hayler L, Ellickalpulthenpura B, Kilgore K, Basen-Engquist K, Carmack Taylor C, Shinn EH. Factors Associated with Sexual Interest and Satisfaction in Ovarian Cancer Patients on Chemotherapy. Annals of Behavioral Medicine 31:S142, 2006. e-Pub 2006.
      22. Kilgore K, Hayler L, Ellickalputhenpura B, Shinn EH. Factors Associated with Worry about Death and Loss of Hope in Late-Stage Cancer Patients. Annals of Behavioral Medicine 31:S142, 2006. e-Pub 2006.
      23. Shinn E, Thornton B, Basen-Engquist K. Depressive symptoms and health behaviors in testicular cancer survivors. Annals of Behavioral Medicine 27:S013, 2004. e-Pub 2004.
      24. Basen-Engquist K, Carmack Taylor C, Shinn E, Lee J. Type and dimensions of breast cancer survivors' physical activity: relationship to quality of life. Annals of Behavioral Medicine 27:S180, 2004. e-Pub 2004.
      25. Shinn E, Basen-Engquist K, Carmack Taylor C, Boling W, Rodriguez A, McKirahan N, Rosenblum C, Olvera N, Valero V, Nazario N, Rivera E. Depression and health behaviors in breast cancer survivors. Annals of Behavioral Medicine 24:S061, 2003. e-Pub 2003.
      26. Boling W, Carmack Taylor C, Shinn E, Dijk F, Zijlstra R, Bevers TB, Basen-Engquist K. Breast Cancer Survivors and Physical Activity: Accuracy of Self-Report with Surgeon General's Recommendations. Annals of Behavioral Medicine 24:S163, 2002. e-Pub 2002.
      27. Thornton B, Shinn E, Basen-Engquist K, de Moor C, Gritz E. Psychological distress and long-term toxicity in testicular cancer survivors. Annals of Behavioral Medicine 23(suppl):S178, 2001. e-Pub 2001.
      28. Shinn E, Thornton B, Basen-Engquist K, de Moor C, Gritz E. Depressive symptoms and health behaviors in testicular cancer survivors. Annals of Behavioral Medicine 23:S081, 2001. e-Pub 2001.
      29. Basen-Engquist K, de Moor C, Thornton B, Shinn E, Gritz E. Quality of life and psychological distress in survivors of testis cancer. Annals of Behavioral Medicine 23:S188, 2001. e-Pub 2001.
      30. Bellush LL, Huh E. Diabetes-induced alterations in 5-HT receptor subtype activation, 1993. e-Pub 1993.

      Book Chapters

      1. Shinn, EH, Chopra, DA. Psychosocial considerations in head and neck cancer. In: Head and neck cancer rehabilitation, 283-302, 2024.
      2. Carmack CL, Parker P, Shinn E. The clinical assessment of distress. In: M. D. Anderson Manual of Psychosocial Oncology. McGraw Hill, 2010.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 01, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top